DrugsControl Media Services

News Detail

GST probe wing set to widen scrutiny of pharma companies (04-06-2024)

New Delhi, 4 June 2024: The Directorate General of GST Intelligence (DGGI) is set to intensify the scrutiny of suspected tax evasion by pharmaceutical companies, over non-payment of dues. In addition to the notices sent already, the DGGI is likely to ask many more companies to ex......
View Details

Source : The Financial Express
DGGI GST input tax credit pharmaceutical companies

Related News